{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:06:48Z","timestamp":1792192008844,"version":"4.4.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2TR001441-06"],"award-info":[{"award-number":["KL2TR001441-06"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK106229"],"award-info":[{"award-number":["R01DK106229"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R41DK119052-01"],"award-info":[{"award-number":["1R41DK119052-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"United States Department of Defense","doi-asserted-by":"crossref","award":["PR180216"],"award-info":[{"award-number":["PR180216"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Obesity is a large and growing global health problem with few effective therapies. The present study investigated metabolic and physiological benefits of nicotinamide N-methyltransferase inhibitor (NNMTi) treatment combined with a lean diet substitution in diet-induced obese mice. NNMTi treatment combined with lean diet substitution accelerated and improved body weight and fat loss, increased whole-body lean mass to body weight ratio, reduced liver and epididymal white adipose tissue weights, decreased liver adiposity, and improved hepatic steatosis, relative to a lean diet substitution alone. Importantly, combined lean diet and NNMTi treatment normalized body composition and liver adiposity parameters to levels observed in age-matched lean diet control mice. NNMTi treatment produced a unique metabolomic signature in adipose tissue, with predominant increases in ketogenic amino acid abundance and alterations to metabolites linked to energy metabolic pathways. Taken together, NNMTi treatment\u2019s modulation of body weight, adiposity, liver physiology, and the adipose tissue metabolome strongly support it as a promising therapeutic for obesity and obesity-driven comorbidities.<\/jats:p>","DOI":"10.1038\/s41598-021-85051-6","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T11:03:49Z","timestamp":1615460629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Combined nicotinamide N-methyltransferase inhibition and reduced-calorie diet normalizes body composition and enhances metabolic benefits in obese mice"],"prefix":"10.1038","volume":"11","author":[{"given":"Catherine M.","family":"Sampson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2214-3670","authenticated-orcid":false,"given":"Andrea L.","family":"Dimet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2913-1824","authenticated-orcid":false,"given":"Harshini","family":"Neelakantan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehinde O.","family":"Ogunseye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8305-3746","authenticated-orcid":false,"given":"Jonathan D.","family":"Hommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley J.","family":"Watowich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"85051_CR1","unstructured":"Prevalence of obesity and severe obesity among adults: United States, 2017\u20132018. (2020)."},{"issue":"4","key":"85051_CR2","doi-asserted-by":"publisher","first-page":"e1000058","DOI":"10.1371\/journal.pmed.1000058","volume":"6","author":"G Danaei","year":"2009","unstructured":"Danaei, G. et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 6(4), e1000058. https:\/\/doi.org\/10.1371\/journal.pmed.1000058 (2009).","journal-title":"PLoS Med."},{"key":"85051_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2458-9-88","volume":"9","author":"DP Guh","year":"2009","unstructured":"Guh, D. P. et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 9, 88. https:\/\/doi.org\/10.1186\/1471-2458-9-88 (2009).","journal-title":"BMC Public Health"},{"issue":"18","key":"85051_CR4","doi-asserted-by":"publisher","first-page":"e476","DOI":"10.1161\/01.CIR.0000140114.83145.59","volume":"110","author":"ID Caterson","year":"2004","unstructured":"Caterson, I. D. et al. Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group III: worldwide comorbidities of obesity. Circulation 110(18), e476\u2013e483. https:\/\/doi.org\/10.1161\/01.CIR.0000140114.83145.59 (2004).","journal-title":"Circulation"},{"key":"85051_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/nyas.12016","volume":"1281","author":"HC Masuoka","year":"2013","unstructured":"Masuoka, H. C. & Chalasani, N. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Ann. N Y Acad. Sci. 1281, 106\u2013122. https:\/\/doi.org\/10.1111\/nyas.12016 (2013).","journal-title":"Ann. N Y Acad. Sci."},{"issue":"92","key":"85051_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.metabol.2018.10.010","volume":"03","author":"E Pilitsi","year":"2019","unstructured":"Pilitsi, E. et al. Pharmacotherapy of obesity: Available medications and drugs under investigation. Metabolism 03(92), 170\u2013192. https:\/\/doi.org\/10.1016\/j.metabol.2018.10.010 (2019).","journal-title":"Metabolism"},{"issue":"25 Suppl 2","key":"85051_CR7","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","volume":"129","author":"MD Jensen","year":"2014","unstructured":"Jensen, M. D. et al. 2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 129(25 Suppl 2), S102\u2013S138. https:\/\/doi.org\/10.1161\/01.cir.0000437739.71477.ee (2014).","journal-title":"Circulation"},{"issue":"5","key":"85051_CR8","doi-asserted-by":"publisher","first-page":"456","DOI":"10.7861\/clinmedicine.12-5-456","volume":"12","author":"R Carter","year":"2012","unstructured":"Carter, R., Mouralidarane, A., Ray, S., Soeda, J. & Oben, J. Recent advancements in drug treatment of obesity. Clin. Med. (Lond). 12(5), 456\u2013460. https:\/\/doi.org\/10.7861\/clinmedicine.12-5-456 (2012).","journal-title":"Clin. Med. (Lond)."},{"key":"85051_CR9","unstructured":"Glykofrydi, S., Kokkinos, A., Barber, T. M., Mastorakos, G., & Valsamakis, G. Existing and Emerging Molecular Targets for the Pharmacotherapy of Obesity. In: Feingold, K.R., Anawalt, B., Boyce, A, et al, eds. Endotext [Internet]. MDText.com, Inc.; 2020."},{"issue":"2","key":"85051_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.atherosclerosis.2008.09.015","volume":"204","author":"M Riederer","year":"2009","unstructured":"Riederer, M., Erwa, W., Zimmermann, R., Frank, S. & Zechner, R. Adipose tissue as a source of nicotinamide N-methyltransferase and homocysteine. Atherosclerosis 204(2), 412\u2013417. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.09.015 (2009).","journal-title":"Atherosclerosis"},{"issue":"7495","key":"85051_CR11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nature13198","volume":"508","author":"D Kraus","year":"2014","unstructured":"Kraus, D. et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature 508(7495), 258\u2013262. https:\/\/doi.org\/10.1038\/nature13198 (2014).","journal-title":"Nature"},{"key":"85051_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bcp.2017.11.007","volume":"147","author":"H Neelakantan","year":"2018","unstructured":"Neelakantan, H. et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochem. Pharmacol. 147, 141\u2013152. https:\/\/doi.org\/10.1016\/j.bcp.2017.11.007 (2018).","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"85051_CR13","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1038\/s41598-018-22081-7","volume":"8","author":"A Kannt","year":"2018","unstructured":"Kannt, A. et al. A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders. Sci. Rep. 8(1), 3660. https:\/\/doi.org\/10.1038\/s41598-018-22081-7 (2018).","journal-title":"Sci. Rep."},{"issue":"4","key":"85051_CR14","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00125-014-3490-7","volume":"58","author":"A Kannt","year":"2015","unstructured":"Kannt, A. et al. Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance. Diabetologia 58(4), 799\u2013808. https:\/\/doi.org\/10.1007\/s00125-014-3490-7 (2015).","journal-title":"Diabetologia"},{"issue":"8","key":"85051_CR15","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1210\/jc.2015-1732","volume":"100","author":"M Liu","year":"2015","unstructured":"Liu, M. et al. Serum N(1)-methylnicotinamide is associated with obesity and diabetes in Chinese. J. Clin. Endocrinol. Metab. 100(8), 3112\u20133117. https:\/\/doi.org\/10.1210\/jc.2015-1732 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"85051_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.tem.2017.02.004","volume":"28","author":"P Pissios","year":"2017","unstructured":"Pissios, P. Nicotinamide N-methyltransferase: More than a vitamin B3 clearance enzyme. Trends Endocrinol. Metab. 28(5), 340\u2013353. https:\/\/doi.org\/10.1016\/j.tem.2017.02.004 (2017).","journal-title":"Trends Endocrinol. Metab."},{"key":"85051_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1146\/annurev-cellbio-100814-125544","volume":"31","author":"R Janke","year":"2015","unstructured":"Janke, R., Dodson, A. E. & Rine, J. Metabolism and epigenetics. Annu. Rev. Cell. Dev. Biol. 31, 473\u2013496. https:\/\/doi.org\/10.1146\/annurev-cellbio-100814-125544 (2015).","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"issue":"1","key":"85051_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cmet.2015.05.023","volume":"22","author":"C Canto","year":"2015","unstructured":"Canto, C., Menzies, K. J. & Auwerx, J. NAD(+) metabolism and the control of energy homeostasis: A balancing act between mitochondria and the nucleus. Cell Metab. 22(1), 31\u201353. https:\/\/doi.org\/10.1016\/j.cmet.2015.05.023 (2015).","journal-title":"Cell Metab."},{"issue":"1","key":"85051_CR19","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1038\/s41598-018-21099-1","volume":"8","author":"K Str\u00f6m","year":"2018","unstructured":"Str\u00f6m, K. et al. N1-methylnicotinamide is a signalling molecule produced in skeletal muscle coordinating energy metabolism. Sci. Rep. 8(1), 3016. https:\/\/doi.org\/10.1038\/s41598-018-21099-1 (2018).","journal-title":"Sci. Rep."},{"key":"85051_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.bcp.2019.02.008","volume":"163","author":"H Neelakantan","year":"2019","unstructured":"Neelakantan, H. et al. Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle. Biochem. Pharmacol. 163, 481\u2013492. https:\/\/doi.org\/10.1016\/j.bcp.2019.02.008 (2019).","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"85051_CR21","doi-asserted-by":"publisher","first-page":"8637","DOI":"10.1038\/s41598-018-26882-8","volume":"8","author":"M Komatsu","year":"2018","unstructured":"Komatsu, M. et al. NNMT activation can contribute to the development of fatty liver disease by modulating the NAD. Sci. Rep. 8(1), 8637. https:\/\/doi.org\/10.1038\/s41598-018-26882-8 (2018).","journal-title":"Sci. Rep."},{"issue":"1","key":"85051_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/07435800.2017.1381972","volume":"43","author":"B Rudolphi","year":"2018","unstructured":"Rudolphi, B. et al. Body weight predicts Nicotinamide N-Methyltransferase activity in mouse fat. Endocr. Res. 43(1), 55\u201363. https:\/\/doi.org\/10.1080\/07435800.2017.1381972 (2018).","journal-title":"Endocr. Res."},{"issue":"12","key":"85051_CR23","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1021\/acs.jmedchem.7b00389","volume":"60","author":"H Neelakantan","year":"2017","unstructured":"Neelakantan, H. et al. Structure-activity relationship for small molecule inhibitors of nicotinamide N-methyltransferase. J. Med. Chem. 60(12), 5015\u20135028. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00389 (2017).","journal-title":"J. Med. Chem."},{"issue":"12","key":"85051_CR24","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1021\/pr5005828","volume":"13","author":"D Meierhofer","year":"2014","unstructured":"Meierhofer, D., Weidner, C. & Sauer, S. Integrative analysis of transcriptomics, proteomics, and metabolomics data of white adipose and liver tissue of high-fat diet and rosiglitazone-treated insulin-resistant mice identified pathway alterations and molecular hubs. J. Proteome Res. 13(12), 5592\u20135602. https:\/\/doi.org\/10.1021\/pr5005828 (2014).","journal-title":"J. Proteome Res."},{"issue":"11","key":"85051_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms18112263","volume":"18","author":"M Riera-Borrull","year":"2017","unstructured":"Riera-Borrull, M. et al. Metformin potentiates the benefits of dietary restraint: a metabolomic study. Int. J. Mol. Sci. 18(11), 1. https:\/\/doi.org\/10.3390\/ijms18112263 (2017).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"85051_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cmet.2007.11.006","volume":"7","author":"B Schwer","year":"2008","unstructured":"Schwer, B. & Verdin, E. Conserved metabolic regulatory functions of sirtuins. Cell Metab. 7(2), 104\u2013112. https:\/\/doi.org\/10.1016\/j.cmet.2007.11.006 (2008).","journal-title":"Cell Metab."},{"issue":"3","key":"85051_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00335-003-2307-7","volume":"15","author":"VJ Bolivar","year":"2004","unstructured":"Bolivar, V. J. & Flaherty, L. Genetic control of novel food preference in mice. Mamm Genome. 15(3), 193\u2013198. https:\/\/doi.org\/10.1007\/s00335-003-2307-7 (2004).","journal-title":"Mamm Genome."},{"key":"85051_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fnut.2016.00010","volume":"3","author":"DE Chusyd","year":"2016","unstructured":"Chusyd, D. E., Wang, D., Huffman, D. M. & Nagy, T. R. Relationships between rodent white adipose fat pads and human white adipose fat depots. Front. Nutr. 3, 10. https:\/\/doi.org\/10.3389\/fnut.2016.00010 (2016).","journal-title":"Front. Nutr."},{"issue":"19","key":"85051_CR29","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.3748\/wjg.v18.i19.2300","volume":"18","author":"Y Takahashi","year":"2012","unstructured":"Takahashi, Y., Soejima, Y. & Fukusato, T. Animal models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. World J. Gastroenterol. 18(19), 2300\u20132308. https:\/\/doi.org\/10.3748\/wjg.v18.i19.2300 (2012).","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"85051_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1872-034X.2007.00008.x","volume":"37","author":"M Ito","year":"2007","unstructured":"Ito, M. et al. Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet. Hepatol. Res. 37(1), 50\u201357. https:\/\/doi.org\/10.1111\/j.1872-034X.2007.00008.x (2007).","journal-title":"Hepatol. Res."},{"issue":"6","key":"85051_CR31","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6), 1313\u20131321. https:\/\/doi.org\/10.1002\/hep.20701 (2005).","journal-title":"Hepatology"},{"key":"85051_CR32","doi-asserted-by":"crossref","unstructured":"Smith, G.S., Walter, G.L., & Walker, R.M. Clinical Pathology in Non-Clinical Toxicology Testing. In: Haschek, W.M., Rousseaux, C.G., Wallig, M.A., eds. Haschek and Rousseaux's Handbook of Toxicologic Pathology. 3rd ed. Academic Press 565\u2013594:chap 18 (2013).","DOI":"10.1016\/B978-0-12-415759-0.00018-2"},{"issue":"9","key":"85051_CR33","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1021\/acschembio.8b00578","volume":"13","author":"VV Nemmara","year":"2018","unstructured":"Nemmara, V. V. et al. Citrullination Inactivates Nicotinamide- N-methyltransferase. ACS Chem. Biol. 13(9), 2663\u20132672. https:\/\/doi.org\/10.1021\/acschembio.8b00578 (2018).","journal-title":"ACS Chem. Biol."},{"key":"85051_CR34","unstructured":"Guide for the care and use of laboratory animals. 8th ed ed. National Academies Press (2011)."},{"issue":"8","key":"85051_CR35","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/oby.2009.471","volume":"18","author":"JP Nixon","year":"2010","unstructured":"Nixon, J. P. et al. Evaluation of a quantitative magnetic resonance imaging system for whole body composition analysis in rodents. Obesity (Silver Spring). 18(8), 1652\u20131659. https:\/\/doi.org\/10.1038\/oby.2009.471 (2010).","journal-title":"Obesity (Silver Spring)."},{"issue":"4","key":"85051_CR36","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-313X.2007.03387.x","volume":"53","author":"O Fiehn","year":"2008","unstructured":"Fiehn, O. et al. Quality control for plant metabolomics: Reporting MSI-compliant studies. Plant J. 53(4), 691\u2013704. https:\/\/doi.org\/10.1111\/j.1365-313X.2007.03387.x (2008).","journal-title":"Plant J."},{"issue":"1","key":"85051_CR37","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1002\/cpbi.86","volume":"68","author":"J Chong","year":"2019","unstructured":"Chong, J., Wishart, D. S. & Xia, J. Using MetaboAnalyst 40 for comprehensive and integrative metabolomics data analysis. Curr. Protoc. Bioinformatics. 68(1), e86. https:\/\/doi.org\/10.1002\/cpbi.86 (2019).","journal-title":"Curr. Protoc. Bioinformatics."},{"issue":"4","key":"85051_CR38","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.neuroimage.2012.07.040","volume":"63","author":"PT Reiss","year":"2012","unstructured":"Reiss, P. T., Schwartzman, A., Lu, F., Huang, L. & Proal, E. Paradoxical results of adaptive false discovery rate procedures in neuroimaging studies. Neuroimage 63(4), 1833\u20131840. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.07.040 (2012).","journal-title":"Neuroimage"},{"issue":"1","key":"85051_CR39","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani, N. et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67(1), 328\u2013357. https:\/\/doi.org\/10.1002\/hep.29367 (2018).","journal-title":"Hepatology"},{"key":"85051_CR40","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-nutr-080508-141200","volume":"29","author":"F Magkos","year":"2009","unstructured":"Magkos, F., Yannakoulia, M., Chan, J. L. & Mantzoros, C. S. Management of the metabolic syndrome and type 2 diabetes through lifestyle modification. Annu. Rev. Nutr. 29, 223\u2013256. https:\/\/doi.org\/10.1146\/annurev-nutr-080508-141200 (2009).","journal-title":"Annu. Rev. Nutr."},{"issue":"6","key":"85051_CR41","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jhepr.2019.10.008","volume":"1","author":"K Hallsworth","year":"2019","unstructured":"Hallsworth, K. & Adams, L. A. Lifestyle modification in NAFLD\/NASH: Facts and figures. JHEP Rep. 1(6), 468\u2013479. https:\/\/doi.org\/10.1016\/j.jhepr.2019.10.008 (2019).","journal-title":"JHEP Rep."},{"issue":"9","key":"85051_CR42","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.2105\/AJPH.2015.302773","volume":"105","author":"A Fildes","year":"2015","unstructured":"Fildes, A. et al. Probability of an obese person attaining normal body weight: Cohort study using electronic health records. Am. J. Public Health. 105(9), e54\u2013e59. https:\/\/doi.org\/10.2105\/AJPH.2015.302773 (2015).","journal-title":"Am. J. Public Health."},{"issue":"12","key":"85051_CR43","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/j.1467-789X.2010.00740.x","volume":"11","author":"JC Barte","year":"2010","unstructured":"Barte, J. C. et al. Maintenance of weight loss after lifestyle interventions for overweight and obesity, a systematic review. Obes. Rev. 11(12), 899\u2013906. https:\/\/doi.org\/10.1111\/j.1467-789X.2010.00740.x (2010).","journal-title":"Obes. Rev."},{"issue":"10","key":"85051_CR44","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/sj.ijo.0803015","volume":"29","author":"CC Curioni","year":"2005","unstructured":"Curioni, C. C. & Louren\u00e7o, P. M. Long-term weight loss after diet and exercise: A systematic review. Int. J. Obes (Lond). 29(10), 1168\u20131174. https:\/\/doi.org\/10.1038\/sj.ijo.0803015 (2005).","journal-title":"Int. J. Obes (Lond)."},{"issue":"5","key":"85051_CR45","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/ajcn\/74.5.579","volume":"74","author":"JW Anderson","year":"2001","unstructured":"Anderson, J. W., Konz, E. C., Frederich, R. C. & Wood, C. L. Long-term weight-loss maintenance: A meta-analysis of US studies. Am. J. Clin. Nutr. 74(5), 579\u2013584. https:\/\/doi.org\/10.1093\/ajcn\/74.5.579 (2001).","journal-title":"Am. J. Clin. Nutr."},{"key":"85051_CR46","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.physbeh.2013.07.009","volume":"120","author":"CN Ochner","year":"2013","unstructured":"Ochner, C. N., Barrios, D. M., Lee, C. D. & Pi-Sunyer, F. X. Biological mechanisms that promote weight regain following weight loss in obese humans. Physiol. Behav. 120, 106\u2013113. https:\/\/doi.org\/10.1016\/j.physbeh.2013.07.009 (2013).","journal-title":"Physiol. Behav."},{"key":"85051_CR47","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.nutr.21.1.323","volume":"21","author":"RR Wing","year":"2001","unstructured":"Wing, R. R. & Hill, J. O. Successful weight loss maintenance. Annu. Rev. Nutr. 21, 323\u2013341. https:\/\/doi.org\/10.1146\/annurev.nutr.21.1.323 (2001).","journal-title":"Annu. Rev. Nutr."},{"key":"85051_CR48","doi-asserted-by":"publisher","unstructured":"Monnier, L., Schlienger, J.L., Colette, C., & Bonnet, F. The obesity treatment dilemma: Why dieting is both the answer and the problem? A mechanistic overview. Diabetes Metab. https:\/\/doi.org\/10.1016\/j.diabet.2020.09.002 (2020).","DOI":"10.1016\/j.diabet.2020.09.002"},{"key":"85051_CR49","doi-asserted-by":"publisher","unstructured":"Brachs, S., Polack, J., & Brachs, M., et al. Genetic nicotinamide N-methyltransferase (Nnmt) deficiency in male mice improves insulin sensitivity in diet-induced obesity but does not affect glucose tolerance. Diabetes. 68(3):527\u2013542. doi:https:\/\/doi.org\/10.2337\/db18-0780 (2019).","DOI":"10.2337\/db18-0780"},{"issue":"10","key":"85051_CR50","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0006-2952(97)00325-0","volume":"54","author":"L Yan","year":"1997","unstructured":"Yan, L., Otterness, D. M., Craddock, T. L. & Weinshilboum, R. M. Mouse liver nicotinamide N-methyltransferase: cDNA cloning, expression, and nucleotide sequence polymorphisms. Biochem. Pharmacol. 54(10), 1139\u20131149 (1997).","journal-title":"Biochem. Pharmacol."},{"key":"85051_CR51","doi-asserted-by":"crossref","unstructured":"Aksoy S, Szumlanski CL, Weinshilboum RM. Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. J. Biol. Chem. 269(20):14835\u201314840 (1994).","DOI":"10.1016\/S0021-9258(17)36700-5"},{"issue":"16","key":"85051_CR52","doi-asserted-by":"publisher","first-page":"673","DOI":"10.4254\/wjh.v8.i16.673","volume":"8","author":"MN Kristiansen","year":"2016","unstructured":"Kristiansen, M. N. et al. Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy. World J. Hepatol. 8(16), 673\u2013684. https:\/\/doi.org\/10.4254\/wjh.v8.i16.673 (2016).","journal-title":"World J. Hepatol."},{"issue":"3","key":"85051_CR53","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jhep.2010.11.021","volume":"55","author":"S Tandra","year":"2011","unstructured":"Tandra, S. et al. Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease. J. Hepatol. 55(3), 654\u2013659. https:\/\/doi.org\/10.1016\/j.jhep.2010.11.021 (2011).","journal-title":"J. Hepatol."},{"key":"85051_CR54","first-page":"1475","volume":"10","author":"EM Brunt","year":"2005","unstructured":"Brunt, E. M. & Tiniakos, D. G. Pathological features of NASH. Front. Biosci. 10, 1475\u20131484 (2005).","journal-title":"Front. Biosci."},{"issue":"4","key":"85051_CR55","doi-asserted-by":"publisher","first-page":"256","DOI":"10.18632\/aging.100738","volume":"7","author":"RA van der Heijden","year":"2015","unstructured":"van der Heijden, R. A. et al. High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL\/6j mice. Aging (Albany NY). 7(4), 256\u2013268. https:\/\/doi.org\/10.18632\/aging.100738 (2015).","journal-title":"Aging (Albany NY)."},{"key":"85051_CR56","doi-asserted-by":"publisher","unstructured":"Neeland IJ, Boone SC, Mook-Kanamori DO, et al. Metabolomics profiling of visceral adipose tissue: results from MESA and the NEO Study. J. Am. Heart Assoc. 8(9):e010810. doi:https:\/\/doi.org\/10.1161\/JAHA.118.010810 (2019)","DOI":"10.1161\/JAHA.118.010810"},{"issue":"6","key":"85051_CR57","doi-asserted-by":"publisher","first-page":"E1552","DOI":"10.1152\/ajpendo.00134.2007","volume":"293","author":"P She","year":"2007","unstructured":"She, P. et al. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am. J. Physiol. Endocrinol. Metab. 293(6), E1552\u2013E1563. https:\/\/doi.org\/10.1152\/ajpendo.00134.2007 (2007).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"85051_CR58","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/MCO.0b013e32834d199f","volume":"15","author":"AK Elshorbagy","year":"2012","unstructured":"Elshorbagy, A. K., Kozich, V., Smith, A. D. & Refsum, H. Cysteine and obesity: Consistency of the evidence across epidemiologic, animal and cellular studies. Curr. Opin. Clin. Nutr. Metab. Care. 15(1), 49\u201357. https:\/\/doi.org\/10.1097\/MCO.0b013e32834d199f (2012).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"issue":"15","key":"85051_CR59","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJM196910092811503","volume":"281","author":"P Felig","year":"1969","unstructured":"Felig, P., Marliss, E. & Cahill, G. F. Plasma amino acid levels and insulin secretion in obesity. N. Engl. J. Med. 281(15), 811\u2013816. https:\/\/doi.org\/10.1056\/NEJM196910092811503 (1969).","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"85051_CR60","doi-asserted-by":"publisher","first-page":"E1175","DOI":"10.1152\/ajpendo.00630.2012","volume":"304","author":"DE Lackey","year":"2013","unstructured":"Lackey, D. E. et al. Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Am. J. Physiol. Endocrinol. Metab. 304(11), E1175\u2013E1187. https:\/\/doi.org\/10.1152\/ajpendo.00630.2012 (2013).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"15","key":"85051_CR61","doi-asserted-by":"publisher","first-page":"11348","DOI":"10.1074\/jbc.M109.075184","volume":"285","author":"MA Herman","year":"2010","unstructured":"Herman, M. A., She, P., Peroni, O. D., Lynch, C. J. & Kahn, B. B. Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. J. Biol. Chem. 285(15), 11348\u201311356. https:\/\/doi.org\/10.1074\/jbc.M109.075184 (2010).","journal-title":"J. Biol. Chem."},{"issue":"4","key":"85051_CR62","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard, C. B. et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9(4), 311\u2013326. https:\/\/doi.org\/10.1016\/j.cmet.2009.02.002 (2009).","journal-title":"Cell Metab."},{"issue":"1","key":"85051_CR63","doi-asserted-by":"publisher","first-page":"173S","DOI":"10.3945\/an.115.011130","volume":"8","author":"ME Frigolet","year":"2017","unstructured":"Frigolet, M. E. & Guti\u00e9rrez-Aguilar, R. The role of the novel lipokine palmitoleic acid in health and disease. Adv. Nutr. 8(1), 173S-181S. https:\/\/doi.org\/10.3945\/an.115.011130 (2017).","journal-title":"Adv. Nutr."},{"issue":"6","key":"85051_CR64","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2008.07.048","volume":"134","author":"H Cao","year":"2008","unstructured":"Cao, H. et al. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 134(6), 933\u2013944. https:\/\/doi.org\/10.1016\/j.cell.2008.07.048 (2008).","journal-title":"Cell"},{"issue":"1","key":"85051_CR65","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0005-2760(74)90046-0","volume":"337","author":"I Bj\u00f6rkhem","year":"1974","unstructured":"Bj\u00f6rkhem, I. & Karlmar, K. E. Biosynthesis of cholestanol: conversion of cholesterol into 4-cholesten-3-one by rat liver microsomes. Biochim. Biophys. Acta. 337(1), 129\u2013131. https:\/\/doi.org\/10.1016\/0005-2760(74)90046-0 (1974).","journal-title":"Biochim. Biophys. Acta."},{"issue":"3","key":"85051_CR66","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1042\/BJ20080709","volume":"413","author":"S Jitrapakdee","year":"2008","unstructured":"Jitrapakdee, S. et al. Structure, mechanism and regulation of pyruvate carboxylase. Biochem. J. 413(3), 369\u2013387. https:\/\/doi.org\/10.1042\/BJ20080709 (2008).","journal-title":"Biochem. J."},{"issue":"6","key":"85051_CR67","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ymben.2009.08.001","volume":"11","author":"Y Si","year":"2009","unstructured":"Si, Y., Shi, H. & Lee, K. Impact of perturbed pyruvate metabolism on adipocyte triglyceride accumulation. Metab. Eng. 11(6), 382\u2013390. https:\/\/doi.org\/10.1016\/j.ymben.2009.08.001 (2009).","journal-title":"Metab. Eng."},{"issue":"6","key":"85051_CR68","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","volume":"15","author":"C Canto","year":"2012","unstructured":"Canto, C. et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 15(6), 838\u2013847. https:\/\/doi.org\/10.1016\/j.cmet.2012.04.022 (2012).","journal-title":"Cell Metab."},{"issue":"4","key":"85051_CR69","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cmet.2010.09.004","volume":"12","author":"R Teperino","year":"2010","unstructured":"Teperino, R., Schoonjans, K. & Auwerx, J. Histone methyl transferases and demethylases; can they link metabolism and transcription?. Cell Metab. 12(4), 321\u2013327. https:\/\/doi.org\/10.1016\/j.cmet.2010.09.004 (2010).","journal-title":"Cell Metab."},{"issue":"7","key":"85051_CR70","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1080\/07391102.2019.1645732","volume":"38","author":"TT Liu","year":"2020","unstructured":"Liu, T. T., Su, W. C., Chen, Q. X., Shen, D. Y. & Zhuang, J. X. The inhibitory kinetics and mechanism of glycolic acid on lipase. J. Biomol. Struct. Dyn. 38(7), 2021\u20132028. https:\/\/doi.org\/10.1080\/07391102.2019.1645732 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"2","key":"85051_CR71","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/nu8020068","volume":"8","author":"DO Kennedy","year":"2016","unstructured":"Kennedy, D. O. B Vitamins and the brain: mechanisms, dose and efficacy\u2013a review. Nutrients. 8(2), 68. https:\/\/doi.org\/10.3390\/nu8020068 (2016).","journal-title":"Nutrients."},{"issue":"3","key":"85051_CR72","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1042\/BJ20110293","volume":"438","author":"ER Werner","year":"2011","unstructured":"Werner, E. R., Blau, N. & Th\u00f6ny, B. Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem. J. 438(3), 397\u2013414. https:\/\/doi.org\/10.1042\/BJ20110293 (2011).","journal-title":"Biochem. J."},{"issue":"4","key":"85051_CR73","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/JES.0b013e3182a4e6b6","volume":"41","author":"H Kainulainen","year":"2013","unstructured":"Kainulainen, H., Hulmi, J. J. & Kujala, U. M. Potential role of branched-chain amino acid catabolism in regulating fat oxidation. Exerc. Sport. Sci. Rev. 41(4), 194\u2013200. https:\/\/doi.org\/10.1097\/JES.0b013e3182a4e6b6 (2013).","journal-title":"Exerc. Sport. Sci. Rev."},{"issue":"6","key":"85051_CR74","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.2337\/db07-0123","volume":"56","author":"Y Zhang","year":"2007","unstructured":"Zhang, Y. et al. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes 56(6), 1647\u20131654. https:\/\/doi.org\/10.2337\/db07-0123 (2007).","journal-title":"Diabetes"},{"key":"85051_CR75","doi-asserted-by":"publisher","unstructured":"Yao K, Duan Y, Li F, et al. Leucine in Obesity: Therapeutic Prospects. Trends Pharmacol Sci. 08 2016;37(8):714\u2013727. doi:https:\/\/doi.org\/10.1016\/j.tips.2016.05.004","DOI":"10.1016\/j.tips.2016.05.004"},{"issue":"2","key":"85051_CR76","doi-asserted-by":"publisher","first-page":"e89166","DOI":"10.1371\/journal.pone.0089166","volume":"9","author":"A Bruckbauer","year":"2014","unstructured":"Bruckbauer, A. & Zemel, M. B. Synergistic effects of polyphenols and methylxanthines with Leucine on AMPK\/Sirtuin-mediated metabolism in muscle cells and adipocytes. PLoS ONE 9(2), e89166. https:\/\/doi.org\/10.1371\/journal.pone.0089166 (2014).","journal-title":"PLoS ONE"},{"issue":"8","key":"85051_CR77","doi-asserted-by":"publisher","first-page":"e12057","DOI":"10.1371\/journal.pone.0012057","volume":"5","author":"Y Noguchi","year":"2010","unstructured":"Noguchi, Y. et al. Ketogenic essential amino acids modulate lipid synthetic pathways and prevent hepatic steatosis in mice. PLoS ONE 5(8), e12057. https:\/\/doi.org\/10.1371\/journal.pone.0012057 (2010).","journal-title":"PLoS ONE"},{"issue":"10","key":"85051_CR78","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.bbadis.2013.05.003","volume":"1832","author":"L Xu","year":"2013","unstructured":"Xu, L. et al. Ketogenic essential amino acids replacement diet ameliorated hepatosteatosis with altering autophagy-associated molecules. Biochim. Biophys. Acta. 1832(10), 1605\u20131612. https:\/\/doi.org\/10.1016\/j.bbadis.2013.05.003 (2013).","journal-title":"Biochim. Biophys. Acta."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85051-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85051-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85051-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T05:08:22Z","timestamp":1670044102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85051-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["85051"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-85051-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"assertion":[{"value":"30 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SJW is the founder of Ridgeline Therapeutics, and HN is a paid employee of Ridgeline Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5637"}}